Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2012, Article ID 165879, 8 pages
http://dx.doi.org/10.1155/2012/165879
Research Article

Nuclear Localization of COX-2 in relation to the Expression of Stemness Markers in Urinary Bladder Cancer

1Faculty of Pharmaceutical Sciences, Suzuka University of Medical Science, 3500-3 Minamitamagaki-cho, Suzuka, Mie 513-8670, Japan
2Department of Environmental and Molecular Medicine, Mie University Graduate School of Medicine, Tsu, Mie 514-8507, Japan
3Faculty of Health Science, Suzuka University of Medical Science, Suzuka, Mie 510-0293, Japan
4Departments of Pathology and Urology, Theodor Bilharz Research Institute, Giza, Egypt

Received 28 November 2011; Accepted 12 January 2012

Academic Editor: Antonio Macciò

Copyright © 2012 Raynoo Thanan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. I. Grivennikov, F. R. Greten, and M. Karin, “Immunity, inflammation, and cancer,” Cell, vol. 140, no. 6, pp. 883–899, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. C. La Vecchia, E. Negri, B. D'Avanzo, R. Savoldelli, and S. Franceschi, “Genital and urinary tract diseases and bladder cancer,” Cancer Research, vol. 51, no. 2, pp. 629–631, 1991. View at Google Scholar · View at Scopus
  3. D. S. Michaud, “Chronic inflammation and bladder cancer,” Urologic Oncology, vol. 25, no. 3, pp. 260–268, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. IARC, “Schistosomes, liver flukes and Helicobacter pylori IARC working group on the evaluation of carcinogenic risks to humans. Lyon, 7–14 June 1994,” IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 61, pp. 1–241, 1994. View at Google Scholar
  5. D. Rollinson, “A wake up call for urinary schistosomiasis: reconciling research effort with public health importance,” Parasitology, vol. 136, no. 12, pp. 1593–1610, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. B. J. Vennervald and K. Polman, “Helminths and malignancy,” Parasite Immunology, vol. 31, no. 11, pp. 686–696, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Ohnishi, M. Murata, and S. Kawanishi, “Oxidative DNA damage induced by a metabolite of 2-naphthylamine, a smoking-related bladder carcinogen,” Japanese Journal of Cancer Research, vol. 93, no. 7, pp. 736–743, 2002. View at Google Scholar · View at Scopus
  8. D. R. Shopland, “Tobacco use and its contribution to early cancer mortality with a special emphasis on cigarette smoking,” Environmental Health Perspectives, vol. 103, supplement 8, pp. 131–142, 1995. View at Google Scholar · View at Scopus
  9. J. Bartkova, P. Guldberg, K. Grønbaek et al., “Aberrations of the Chk2 tumour suppressor in advanced urinary bladder cancer,” Oncogene, vol. 23, no. 52, pp. 8545–8551, 2004. View at Publisher · View at Google Scholar
  10. N. Hornigold, J. Devlin, A. M. Davies, J. S. Aveyard, T. Habuchi, and M. A. Knowles, “Mutation of the 9q34 gene TSC1 in sporadic bladder cancer,” Oncogene, vol. 18, no. 16, pp. 2657–2661, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Sanchez-Carbayo, N. D. Socci, T. Kirchoff et al., “A polymorphismin HDM2 (SNP309) associates with early onset in superficial tumors, TP53 mutations, and poor outcome in invasive bladder cancer,” Clinical Cancer Research, vol. 13, no. 11, pp. 3215–3220, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. D. S. Srivastava, A. Mandhani, and R. D. Mittal, “Genetic polymorphisms of cytochrome P450 CYP1A1 (*2A) and microsomal epoxide hydrolase gene, interactions with tobacco-users, and susceptibility to bladder cancer: a study from North India,” Archives of Toxicology, vol. 82, no. 9, pp. 633–639, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. D. S. Srivastava, D. K. Mishra, A. Mandhani, B. Mittal, A. Kumar, and R. D. Mittal, “Association of genetic polymorphism of glutathione S-transferase M1, T1, P1 and susceptibility to bladder cancer,” European Urology, vol. 48, no. 2, pp. 339–344, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Reya, S. J. Morrison, M. F. Clarke, and I. L. Weissman, “Stem cells, cancer, and cancer stem cells,” Nature, vol. 414, no. 6859, pp. 105–111, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Shipitsin and K. Polyak, “The cancer stem cell hypothesis: in search of definitions, markers, and relevance,” Laboratory Investigation, vol. 88, no. 5, pp. 459–463, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Atlasi, S. J. Mowla, S. A. M. Ziaee, and A. R. Bahrami, “OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancer,” International Journal of Cancer, vol. 120, no. 7, pp. 1598–1602, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. C. C. Chang, G. S. Shieh, P. Wu, C. C. Lin, A. L. Shiau, and C. L. Wu, “Oct-3/4 expression reflects tumor progression and regulates motility of bladder cancer cells,” Cancer Research, vol. 68, no. 15, pp. 6281–6291, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Bentivegna, D. Conconi, E. Panzeri et al., “Biological heterogeneity of putative bladder cancer stem-like cell populations from human bladder transitional cell carcinoma samples,” Cancer Science, vol. 101, no. 2, pp. 416–424, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. N. Ma, R. Thanan, H. Kobayashi et al., “Nitrative DNA damage and Oct3/4 expression in urinary bladder cancer with Schistosomahaematobium infection,” Biochemical and Biophysical Research Communications, vol. 414, no. 2, pp. 344–349, 2011. View at Google Scholar
  20. T. Klatte, D. B. Seligson, J. Y. Rao et al., “Absent CD44v6 expression is an independent predictor of poor urothelial bladder cancer outcome,” Journal of Urology, vol. 183, no. 6, pp. 2403–2408, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. K. A. Iczkowski, J. H. Shanks, and D. G. Bostwick, “Loss of CD44 variant 6 expression differentiates small cell carcinoma of urinary bladder from urothelial (transitional cell) carcinoma,” Histopathology, vol. 32, no. 4, pp. 322–327, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. J. S. Ross, A. D. del Rosario, H. X. Bui, B. V. S. Kallakury, N. T. Okby, and J. Figge, “Expression of the CD44 cell adhesion molecule in urinary bladder transitional cell carcinoma,” Modern Pathology, vol. 9, no. 8, pp. 854–860, 1996. View at Google Scholar · View at Scopus
  23. J. Kuncová, M. Urban, and V. Mandys, “Expression of CD44s and CD44v6 in transitional cell carcinomas of the urinary bladder: comparison with tumour grade, proliferative activity and p53 immunoreactivity of tumour cells,” APMIS, vol. 115, no. 11, pp. 1194–1205, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Sugiyama, A. Woodman, T. Sugino et al., “Non-invasive detection of bladder cancer by identification of abnormal CD44 proteins in exfoliated cancer cells in urine,” Journal of Clinical Pathology, vol. 48, no. 3, pp. M142–M147, 1995. View at Google Scholar · View at Scopus
  25. Y. M. Yang and J. W. Chang, “Bladder cancer initiating cells (BCICs) are among EMA-CD44v6+ subset: novel methods for isolating undetermined cancer stem (initiating) cells,” Cancer Investigation, vol. 26, no. 7, pp. 725–733, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Jijiwa, H. Demir, S. Gupta et al., “CD44V6 regulates growth of brain tumor stem cells partially through the AKT-mediated pathway,” Plos ONE, vol. 6, no. 9, Article ID e24217, 2011. View at Publisher · View at Google Scholar
  27. T. E. North, W. Goessling, C. R. Walkley et al., “Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis,” Nature, vol. 447, no. 7147, pp. 1007–1011, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. C. M. Logan, A. Giordano, A. Puca, and M. Cassone, “Prostaglandin E2: at the crossroads between stem cell development, inflammation and cancer,” Cancer Biology and Therapy, vol. 6, no. 10, pp. 1517–1520, 2007. View at Google Scholar · View at Scopus
  29. W. Kitayama, A. Denda, E. Okajima, T. Tsujiuchi, and Y. Konishi, “Increased expression of cyclooxygenase-2 protein in rat urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl) nitrosamine,” Carcinogenesis, vol. 20, no. 12, pp. 2305–2310, 1999. View at Google Scholar · View at Scopus
  30. E. Okajima, A. Denda, S. Ozono et al., “Chemopreventive effects of nimesulide, a selective cyclooxygenase-2 inhibitor, on the development of rat urinary bladder carcinomas initiated by N-butyl-N(4-hydroxybutyl) nitrosamine,” Cancer Research, vol. 58, no. 14, pp. 3028–3031, 1998. View at Google Scholar · View at Scopus
  31. A. Ristimäki, O. Nieminen, K. Saukkonen, K. Hotakainen, S. Nordling, and C. Haglund, “Expression of cyclooxygenase-2 in human transitional cell carcinoma of the urinary bladder,” American Journal of Pathology, vol. 158, no. 3, pp. 849–853, 2001. View at Google Scholar · View at Scopus
  32. T. Shirahama and C. Sakakura, “Overexpression of cyclooxygenase-2 in squamous cell carcinoma of the urinary bladder,” Clinical Cancer Research, vol. 7, no. 3, pp. 558–561, 2001. View at Google Scholar · View at Scopus
  33. O. A. Hammam, A. A. Aziz, M. S. Roshdy, and A. M. Abdel Hadi, “Possible role of cyclooxygenase-2 in schistosomal and non-schistosomal-associated bladder cancer,” Medscape General Medicine, vol. 10, no. 3, article 60, 2008. View at Google Scholar · View at Scopus
  34. J. N. Eble, G. Sauter, J. I. Epstein, and I. A. Sesterhenn, Eds., World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs, IARC Press, Lyon, France, 2004.
  35. F. K. Mostofi, L. H. Sobin, and H. Torloni, Histological Typing of Urinary Bladder Tumours: International Classification of Tumours, no. 10, World Health Organization, Geneva, Switzerland, 1973.
  36. Z. A. Shaker, M. A. Kaddah, S. B. Hanallah, and M. I. El-Khodary, “Production of monoclonal antibodies against target schistosomal antigen secreted in the urine of Schistosoma mansoni-infected patients,” International Journal for Parasitology, vol. 28, no. 12, pp. 1893–1901, 1998. View at Publisher · View at Google Scholar · View at Scopus
  37. N. Ma, Y. Adachi, Y. Hiraku et al., “Accumulation of 8-nitroguanine in human gastric epithelium induced by Helicobacter pylori infection,” Biochemical and Biophysical Research Communications, vol. 319, no. 2, pp. 506–510, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. L. M. Coussens and Z. Werb, “Inflammation and cancer,” Nature, vol. 420, no. 6917, pp. 860–867, 2002. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Rakoff-Nahoum, “Why cancer and inflammation?” Yale Journal of Biology and Medicine, vol. 79, no. 3-4, pp. 123–130, 2006. View at Google Scholar · View at Scopus
  40. N. J. Maitland and A. T. Collins, “Inflammation as the primary aetiological agent of human prostate cancer: a stem cell connection?” Journal of Cellular Biochemistry, vol. 105, no. 4, pp. 931–939, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. T. Tanno and W. Matsui, “Development and maintenance of cancer stem cells under chronic inflammation,” Journal of Nippon Medical School, vol. 78, no. 3, pp. 138–145, 2011. View at Publisher · View at Google Scholar
  42. J. Hoggatt, P. Singh, J. Sampath, and L. M. Pelus, “Prostaglandin E2 enhances hematopoietic stem cell homing, survival, and proliferation,” Blood, vol. 113, no. 22, pp. 5444–5455, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. H. K. Yun and J. H. Ho, “High-glucose-induced prostaglandin E2 and peroxisome proliferator-activated receptor δ promote mouse embryonic stem cell proliferation,” Stem Cells, vol. 26, no. 3, pp. 745–755, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. J. Y. Liou, D. P. Ellent, S. Lee et al., “Cyclooxygenase-2-derived prostaglandin E2 protects mouse embryonic stem cells from apoptosis,” Stem Cells, vol. 25, no. 5, pp. 1096–1103, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. S. P. Yun, J. M. Ryu, M. W. Jang, and H. J. Han, “Interaction of profilin-1 and F-actin via a β-arrestin-1/JNK signaling pathway involved in prostaglandin E2-induced human mesenchymal stem cells migration and proliferation,” Journal of Cellular Physiology, vol. 226, no. 2, pp. 559–571, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. J. A. Rudnick, L. M. Arendt, I. Klebba et al., “Functional heterogeneity of breast fibroblasts is defined by a prostaglandin secretory phenotype that promotes expansion of cancer-stem like cells,” Plos ONE, vol. 6, no. 9, Article ID e24605, 2011. View at Publisher · View at Google Scholar
  47. P. Maroni, E. Matteucci, A. Luzzati, G. Perrucchini, P. Bendinelli, and M. A. Desiderio, “Nuclear co-localization and functional interaction of COX-2 and HIF-1α characterize bone metastasis of human breast carcinoma,” Breast Cancer Research and Treatment, vol. 129, no. 2, pp. 433–450, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. H. Parfenova, V. N. Parfenov, B. V. Shlopov et al., “Dynamics of nuclear localization sites for COX-2 in vascular endothelial cells,” American Journal of Physiology, vol. 281, no. 1, pp. C166–C178, 2001. View at Google Scholar · View at Scopus
  49. T. Burdon, A. Smith, and P. Savatier, “Signalling, cell cycle and pluripotency in embryonic stem cells,” Trends in Cell Biology, vol. 12, no. 9, pp. 432–438, 2002. View at Publisher · View at Google Scholar · View at Scopus
  50. M. H. Rosner, M. A. Vigano, K. Ozato et al., “A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo,” Nature, vol. 345, no. 6277, pp. 686–692, 1990. View at Publisher · View at Google Scholar · View at Scopus
  51. K. Okita, T. Ichisaka, and S. Yamanaka, “Generation of germline-competent induced pluripotent stem cells,” Nature, vol. 448, no. 7151, pp. 313–317, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. I. H. Park, R. Zhao, J. A. West et al., “Reprogramming of human somatic cells to pluripotency with defined factors,” Nature, vol. 451, no. 7175, pp. 141–146, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. J. Yu, M. A. Vodyanik, K. Smuga-Otto et al., “Induced pluripotent stem cell lines derived from human somatic cells,” Science, vol. 318, no. 5858, pp. 1917–1920, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. Y. C. Chen, H. S. Hsu, Y. W. Chen et al., “Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells,” PLoS ONE, vol. 3, no. 7, Article ID e2637, 2008. View at Publisher · View at Google Scholar · View at Scopus
  55. D. Ponti, A. Costa, N. Zaffaroni et al., “Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties,” Cancer Research, vol. 65, no. 13, pp. 5506–5511, 2005. View at Publisher · View at Google Scholar · View at Scopus
  56. H. Ponta, L. Sherman, and P. A. Herrlich, “CD44: from adhesion molecules to signalling regulators,” Nature Reviews Molecular Cell Biology, vol. 4, no. 1, pp. 33–45, 2003. View at Publisher · View at Google Scholar · View at Scopus
  57. K. K. Tanabe, L. M. Ellis, and H. Saya, “Expression of CD44R1 adhesion molecule in colon carcinomas and metastases,” The Lancet, vol. 341, no. 8847, pp. 725–726, 1993. View at Publisher · View at Google Scholar · View at Scopus
  58. A. K. Croker and A. L. Allan, “Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDH(hi)CD44 (+) human breast cancer cells,” Breast Cancer Research and Treatment, pp. 1–13, 2011. View at Publisher · View at Google Scholar
  59. T. Ishimoto, O. Nagano, T. Yae et al., “CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth,” Cancer Cell, vol. 19, no. 3, pp. 387–400, 2011. View at Publisher · View at Google Scholar